Lightpath Technologies LPTH Allocated Share Based Compensation Expense Total

Allocated Share Based Compensation Expense Total at other companies

Option Care Health, Inc.OPCH

1.7%+0.5pp

Certara, Inc.CERT

$7.32M+3.5%

Guardian Pharmacy ServicesGRDN

$1.86M-53.1%

AMN HealthcareAMN

$737K+475%

Distribution Solutions Group, Inc.DSGR

$2.42M+149%

APA

Artisan Partners Asset Management Inc.APAM

$8.39M-1.3%

Other financials

Income statement

See full

Revenue$19.1M+109%

Gross profit$4.5M+57.6%

Operating income-$2.5M-82.0%

Net income-$4.1M-14.6%

EPS (diluted)-$0.07-75.0%

Balance sheet

See full

Cash & equivalents$55.2M+753%

Total debt$11.4M-20.7%

Total equity$89.1M+467%

Total assets$144.3M+77.2%

Cash flow

See full

Operating cash flow-$6.8M-110%

CapEx$899.5K+114%

Free cash flow-$7.7M-110%

Valuation

See full

Market cap$816.26M+518%

Enterprise value$772.4M+452%

P/S13×+9.1×

Profitability

See full

Gross margin26.8%-1.7pp

Operating margin-29.5%+6.9pp

Net margin-37.4%+11.5pp

FCF margin-16.4%-2.1pp

Returns & leverage

See full

Return on equity-44.8%+2.1pp

Debt / equity0.1×-0.8×

Current ratio3.9×+1.6×

Where this comes from

Reported directly by Lightpath Technologies in its filing.

Tagged under the XBRL concept lpth:AllocatedShareBasedCompensationExpenseTotal.

The official record: Lightpath Technologies’s 10-K, filed September 26, 2025, on SEC EDGAR. View the filing →

Ask your AI about Lightpath Technologies's allocated share based compensation expense total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lightpath Technologies's allocated share based compensation expense total?: Lightpath Technologies (LPTH) reported allocated share based compensation expense total of $314.07K in Q2 2025.
What does allocated share based compensation expense total mean?: The total non-cash expense recognized for equity-based awards granted to employees and directors over the reporting period. This metric reflects the cost of compensation provided through stock options, restricted stock, or other equity instruments, impacting the company's overall profitability.